Adeno-Associated Virus Vector Manufacturing Market Analysis Reveals Emerging Opportunities Across Biopharmaceutical Sector
The global Adeno-Associated Virus (AAV) Vector Manufacturing Market has emerged as one of the most dynamic segments within the advanced therapeutics and biopharmaceutical manufacturing industry. The market was valued at USD 1.37 billion in 2025 and is projected to reach USD 8.63 billion by the end of 2035, expanding at a compound annual growth rate (CAGR) of 20.2% during the forecast period (2026–2035).
